(Bloomberg) -- Lars Rebien Sorensen is back as chairman of Novo Nordisk A/S following a shareholder meeting that exposed the depth of rivalry between the Danish drugmaker and US arch nemesis Pfizer ...
Nov 13 (Reuters) - Mikael Dolsten, Pfizer's (PFE.N), opens new tab former research and development chief, has withdrawn his candidacy for Novo Nordisk's (NOVOb.CO), opens new tab board, citing ...
Amid Novo Nordisk and Pfizer’s whiplash contest for obesity biotech Metsera, Novo’s CEO has, quite literally, told his company's rival to put its money where its mouth is. “Novo Nordisk and Pfizer ...
Connecticut-based Pfizer Inc. said Thursday that it has completed the successful acquisition of Metsera, Inc., which is “a clinical-stage biopharmaceutical company accelerating the next generation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback